Sundial Growers Inc. engages in production and marketing of cannabis products for the adult-use market in Canada.
Sundial Growers Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$0.67|
|52 Week High||US$0.14|
|52 Week Low||US$3.96|
|1 Month Change||-13.25%|
|3 Month Change||-30.62%|
|1 Year Change||269.78%|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||-92.06%|
Recent News & Updates
|SNDL||US Pharmaceuticals||US Market|
Return vs Industry: SNDL exceeded the US Pharmaceuticals industry which returned 15.5% over the past year.
Return vs Market: SNDL exceeded the US Market which returned 37.5% over the past year.
Stable Share Price: SNDL is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 8% a week.
Volatility Over Time: SNDL's weekly volatility has decreased from 29% to 8% over the past year.
About the Company
Sundial Growers Inc. engages in production and marketing of cannabis products for the adult-use market in Canada. It produces and distributes inhalable products, such as flower, pre-rolls, and vapes. The company offers its products under the Top Leaf, Sundial Cannabis, Palmetto, and Grasslands brands.
Sundial Growers Fundamentals Summary
|SNDL fundamental statistics|
Is SNDL overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|SNDL income statement (TTM)|
|Cost of Revenue||CA$76.27m|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
|Earnings per share (EPS)||-0.16|
|Net Profit Margin||-703.99%|
How did SNDL perform over the long term?See historical performance and comparison
Is Sundial Growers undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: SNDL ($0.67) is trading above our estimate of fair value ($0.61)
Significantly Below Fair Value: SNDL is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: SNDL is unprofitable, so we can't compare its PE Ratio to the US Pharmaceuticals industry average.
PE vs Market: SNDL is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate SNDL's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: SNDL is good value based on its PB Ratio (1.3x) compared to the US Pharmaceuticals industry average (3.2x).
How is Sundial Growers forecast to perform in the next 1 to 3 years based on estimates from 6 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SNDL is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2%).
Earnings vs Market: SNDL is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: SNDL's is expected to become profitable in the next 3 years.
Revenue vs Market: SNDL's revenue (30.2% per year) is forecast to grow faster than the US market (9.8% per year).
High Growth Revenue: SNDL's revenue (30.2% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if SNDL's Return on Equity is forecast to be high in 3 years time
How has Sundial Growers performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: SNDL is currently unprofitable.
Growing Profit Margin: SNDL is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: SNDL is unprofitable, and losses have increased over the past 5 years at a rate of 50.5% per year.
Accelerating Growth: Unable to compare SNDL's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: SNDL is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (17.5%).
Return on Equity
High ROE: SNDL has a negative Return on Equity (-24.2%), as it is currently unprofitable.
How is Sundial Growers's financial position?
Financial Position Analysis
Short Term Liabilities: SNDL's short term assets (CA$1.1B) exceed its short term liabilities (CA$79.0M).
Long Term Liabilities: SNDL's short term assets (CA$1.1B) exceed its long term liabilities (CA$804.0K).
Debt to Equity History and Analysis
Debt Level: SNDL is debt free.
Reducing Debt: SNDL had no debt 5 years ago.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: SNDL has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if SNDL has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.
What is Sundial Growers's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate SNDL's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate SNDL's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if SNDL's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if SNDL's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of SNDL's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Zach George (43 yo)
Mr. Zachary Ryan George, B.A, J.D., also known as Zach, is a Co-Founder, Managing Member, Partner and Portfolio Manager at FrontFour Capital Group LLC since 2006. Mr. George has been a Director of Sundial...
CEO Compensation Analysis
Compensation vs Market: Zach's total compensation ($USD7.27M) is above average for companies of similar size in the US market ($USD3.67M).
Compensation vs Earnings: Zach's compensation has increased whilst the company is unprofitable.
Experienced Management: SNDL's management team is considered experienced (2.5 years average tenure).
Experienced Board: SNDL's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 1324.4%.
Sundial Growers Inc.'s employee growth, exchange listings and data sources
- Name: Sundial Growers Inc.
- Ticker: SNDL
- Exchange: NasdaqCM
- Founded: 2006
- Industry: Pharmaceuticals
- Sector: Pharmaceuticals & Biotech
- Market Cap: US$1.386b
- Shares outstanding: 2.06b
- Website: https://www.sundialgrowers.com
Number of Employees
- Sundial Growers Inc.
- 919–11 Avenue SW
- Suite 200
- T2R 1P3
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/09/25 02:25|
|End of Day Share Price||2021/09/24 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.